Insider Transactions Reported by 15 Insiders of NEKTAR THERAPEUTICS

Symbol
NKTR on Nasdaq
Location
San Francisco, CA

Insiders trading volume in the past year

NEKTAR THERAPEUTICS executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Deep Track Capital, LP 10%+ Owner $32,635,810 10 May 2024
HOWARD W. ROBIN President & CEO, Director $4,122,022 -$677,382 -14% 22 Dec 2025
Mark A. Wilson Chief Legal Officer $1,171,633 -$70,019 -5.6% 21 Nov 2025
Jonathan Zalevsky Chief R&D Officer $761,697 -$309,887 -29% 20 Jan 2026
Jillian B. Thomsen Chief Financial Officer $153,614 16 Feb 2023
Gil M. Labrucherie Svp, Coo & Cfo $153,323 15 May 2022
JOHN NORTHCOTT SVP & Chief Commercial Officer $109,373 16 May 2022
Myriam Curet Director $13,435 18 Sep 2023
KARIN EASTHAM Director $11,384 16 Sep 2022
ROBERT CHESS Director 30 Sep 2025
Jeffrey Robert Ajer Director 30 Sep 2025
R. SCOTT GREER Director 30 Sep 2025
ROY A. WHITFIELD Director 30 Sep 2025
Diana Brainard Director 30 Sep 2025
SANDRA A. GARDINER Chief Financial Officer 17 Apr 2023

Recent Insider Transactions by Companies or Individuals for NEKTAR THERAPEUTICS

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.